Compare Oracle Corporation (ORCL) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Oracle CorporationTrade

Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Vaxcyte Inc. Common Stock — how do they compare? Oracle Corporation trades at $128.71 (market cap $434.11B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Oracle Corporation is far larger — about 41.3× Vaxcyte Inc. Common Stock's market cap, and Oracle Corporation pays a 1.4% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oracle Corporation for 73 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

	ORCL	PCVX
Market Cap	$434.11B	$10.51B
Volume	25,917,551	2,644,694
Sector	Technology	Health
52-Week High	$313.00	$73.82
52-Week Low	$114.99	$40.32
Typical Hold Time	73 Days	0 Days
Enterprise Value	$557.92B	$9.14B
Dividend Yield	1.4%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle (ORCL) trades at $137.40, down 2.92% on the day amid a bearish technical signal, though it has consistently beaten earnings estimates in recent quarters. Revenue grew to $57.40B in 2025 with a net income margin of 26.36%, while analyst consensus remains strongly bullish with a $236.52 price target. Recent news highlights strong AI cloud demand and restructuring efforts to support growth.

The outlook is positive given robust fundamentals and AI-driven revenue acceleration, but risks include high debt levels, competitive pressures, and market volatility. The stock presents a long-term opportunity if execution on AI infrastructure continues, though near-term price weakness reflects investor caution.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORCL

53% Buy47% Sell

Avg holding period · 73 Days

PCVX

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

ORCL

CoreWeave shares plunge and bond yields spike amid investor fears over AI-related debt risks.CNBC · 17 hours agoBearish Mizuho keeps Oracle price target at $320 despite project delays, sees 123% upside potential.Finbold · 19 hours agoBullish CoreWeave stock drops 10% as bond yields hit 15%, raising concerns over its debt-funded AI growth.24/7 Wall Street · 20 hours agoBearish View details →

PCVX

View details →

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.